TIDES: Oligonucleotide and Peptide® Technology and Product Development 2011

The TIDES® conference has been very successful in maintaining a strong growth pattern even in the recent economically difficult years. The 2011 program included thought-provoking keynotes and featured presentations, an extremely compelling regulatory session and discussions including CBER, FDA and European regulatory agency speakers. In separate tracks for each type of molecule, delegates learned more from the brand new, full-day sessions on CMC: Manufacturing and Analysis of Oligos and Peptides, a full day on formulation and delivery, and updates on compounds in preclinical and clinical development.

Back by popular demand, expanded break-out discussion sessions and pre-conference courses gave opportunities for very lively discussions and skills enhancement.